Drug Profile
Research programme: pyridazinone anti-psychotic therapeutics - Egis Pharmaceuticals/Servier
Alternative Names: EGIS-11148Latest Information Update: 14 Sep 2010
Price :
$50
*
At a glance
- Originator Egis Pharmaceuticals
- Developer Egis Pharmaceuticals; Servier
- Class Ketones; Pyridazines
- Mechanism of Action Alpha 1 adrenergic receptor modulators; Alpha 2 adrenergic receptor agonists; Alpha-2 adrenergic receptor modulators; Dopamine D2 receptor modulators; Serotonin 5-HT2A receptor modulators; Serotonin-6 receptor modulators; Serotonin-7 receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Psychotic disorders; Schizophrenia